Skip to content
2000
Volume 17, Issue 2
  • ISSN: 2589-9775
  • E-ISSN: 2589-9783

Abstract

Background

is an emerging opportunistic pathogen that has been increasingly reported in clinical settings. Despite its low pathogenicity in immunocompetent individuals, it poses a significant threat to immunocompromised patients, particularly those with underlying medical conditions or invasive medical interventions.

Objectives

This study aimed to evaluate the clinical impact and management strategies based on the analysis of individual case reports on

Methods

A comprehensive search of PubMed was conducted from inception until July 31, 2023, using the terms “” and/or “”. Inclusion criteria for our systematic review included human-centered case reports of infections, excluding case series and review articles. Data extraction followed PRISMA guidelines, including study details and patient characteristics. Case reports were systematically assessed using the JBI critical appraisal checklist, evaluating patient demographics, clinical history, diagnostic methods, interventions, post-intervention outcomes, adverse events, and lessons learned to minimize bias risk.

Results

A total of 17 case reports of infections were included in our systematic review. Studies published from 2001 to 2023 revealed diverse global contributions, with 29.41% from China. Infection origins varied, with catheter-related cases being predominant. Mortality was reported in two studies. Antibiotic sensitivity analysis showed sensitivity to third-generation cephalosporins, notably Ceftazidime. Quality appraisal revealed that all studies had a low risk of bias, ensuring the overall robustness of the case reports.

Conclusion

This study emphasizes the importance of understanding infections, given their varied clinical presentations and antibiotic responses. The study also underscores the necessity for precise identification, customized treatments, and ongoing research to manage these infections effectively.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdrr/10.2174/0125899775287020240424071322
2024-05-07
2025-09-26

  • From This Site

    /content/journals/cdrr/10.2174/0125899775287020240424071322
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. VaneechoutteM. KämpferP. De BaereT. FalsenE. VerschraegenG. Wautersia gen. nov., a novel genus accommodating the phylogenetic lineage including Ralstonia eutropha and related species, and proposal of Ralstonia [Pseudomonas] syzygii (Roberts et al. 1990) comb. nov.Int. J. Syst. Evol. Microbiol.200454231732710.1099/ijs.0.02754‑015023939
     [Google Scholar]
  2. FluitA.C. BayjanovJ.R. AguilarM.D. CantónR. TunneyM.M. ElbornJ.S. van WestreenenM. EkkelenkampM.B. Characterization of clinical Ralstonia strains and their taxonomic position.Antonie van Leeuwenhoek2021114101721173310.1007/s10482‑021‑01637‑034463860
     [Google Scholar]
  3. LucarelliC. Di DomenicoE.G. TomaL. BraccoD. PrignanoG. FortunatiM. PelagalliL. EnsoliF. PezzottiP. García-FernándezA. PantostiA. IngrossoL. Ralstonia mannitolilytica infections in an oncologic day ward: description of a cluster among high-risk patients.Antimicrob. Resist. Infect. Control2017612010.1186/s13756‑017‑0178‑z28191308
     [Google Scholar]
  4. RyanM.P. AdleyC.C. Ralstonia spp.: emerging global opportunistic pathogens.Eur. J. Clin. Microbiol. Infect. Dis.201433329130410.1007/s10096‑013‑1975‑924057141
     [Google Scholar]
  5. SiddiquiT. PatelS.S. SinhaR. GhoshalU. SahuC. Ralstonia mannitolilytica: an emerging multidrug-resistant opportunistic pathogen in a tertiary care hospital setting.Access Microbiol.202245acmi00036710.1099/acmi.0.00036736003352
     [Google Scholar]
  6. GermanouD SpernovasilisN PapadopoulosA ChristodoulouS AgouridisAP Infections caused by moellerella wisconsensis: a case report and a systematic review of the literature.Microorganisms202210589210.3390/microorganisms10050892
     [Google Scholar]
  7. VaneechoutteM. De BaereT. WautersG. SteyaertS. ClaeysG. VogelaersD. VerschraegenG. One case each of recurrent meningitis and hemoperitoneum infection with Ralstonia mannitolilytica. J. Clin. Microbiol.200139124588459010.1128/JCM.39.12.4588‑4590.200111724893
     [Google Scholar]
  8. DotisJ. PrintzaN. OrfanouA. PapathanasiouE. PapachristouF. Peritonitis due to Ralstonia mannitolilytica in a pediatric peritoneal dialysis patient.New Microbiol.201235450350623109020
     [Google Scholar]
  9. LiuC.X. YanC. ZhangP. LiF.Q. YangJ.H. LiX.Y. Ralstonia mannitolilytica-induced septicemia and homology analysis in infected patients: 3 case reports.Jundishapur J. Microbiol.201697e3437310.5812/jjm.3437327679705
     [Google Scholar]
  10. ComanI. BilodeauL. LavoieA. CarricartM. TremblayF. ZlosnikJ.E. BerthiaumeY. Ralstonia mannitolilytica in cystic fibrosis: A new predictor of worse outcomes.Respir. Med. Case Rep.201720485010.1016/j.rmcr.2016.11.01427995056
     [Google Scholar]
  11. BoattiniM. BiancoG. BianconeL. CavalloR. CostaC. Ralstonia mannitolilytica bacteraemia: a case report and literature review.Infez. Med.201826437437830555144
     [Google Scholar]
  12. LimC.T.S. LeeS.E. A rare case of Ralstonia mannitolilytica infection in an end stage renal patient on maintenance dialysis during municipal water contamination.Pak. J. Med. Sci.20173341047104910.12669/pjms.334.1311229067090
     [Google Scholar]
  13. OwusuM. AcheampongG. AnnanA. MarfoK.S. OseiI. AmuasiJ. SarpongN. ImJ. MogeniO.D. ChiangH.Y. KuoC.H. JeonH.J. PanznerU. ParkS.E. MarksF. Owusu-DaboE. Adu-SarkodieY. Ralstonia mannitolilytica sepsis: a case report.J. Med. Case Rep.201913131810.1186/s13256‑019‑2235‑031653273
     [Google Scholar]
  14. SharmaD SharmaP SoniP GuptaB Ralstonia picketti neonatal sepsis: a case report.BMC Res Notes20171012810.1186/s13104‑016‑2347‑1
     [Google Scholar]
  15. FangQ FengY FengP WangX ZongZ Nosocomial bloodstream infection and the emerging carbapenem-resistant pathogen Ralstonia insidiosa.BMC Infect Dis201919133410.1186/s12879‑019‑3985‑4
     [Google Scholar]
  16. LinS.Z. QianM.J. WangY.W. ChenQ.D. WangW.Q. LiJ.Y. YangR.T. WangX.Y. MuC.Y. JiangK. Children with infectious pneumonia caused by Ralstonia insidiosa : A case report.World J. Clin. Cases20231192002200810.12998/wjcc.v11.i9.200236998962
     [Google Scholar]
  17. BassoM. VendittiC. RaponiG. NavazioA.S. AlessandriF. GiombiniE. NisiiC. Di CaroA. VendittiM. A case of persistent bacteraemia by Ralstonia mannitolilytica and Ralstonia pickettii in an intensive care unit.Infect. Drug Resist.2019122391239510.2147/IDR.S20649231447567
     [Google Scholar]
  18. CarreiraM. GomesC. SilvaM. DuroR. Ralstonia mannitollylitica endocarditis: A case report.IDCases202022e0100310.1016/j.idcr.2020.e0100333204634
     [Google Scholar]
  19. ZhouS. TangD. WeiS. HuZ. WangX. LuoD. Ralstonia mannitolilytica sepsis after elective cesarean delivery: a case report.BMC Pregnancy Childbirth202121173710.1186/s12884‑021‑04214‑534717569
     [Google Scholar]
  20. TuJ. TuL. JiangY. FuH. MaiZ. WuX. XuB. Sepsis due to bloodstream ralstonia mannitolilytica infection after surgical treatment of perianal abscess: a case report.Infect. Drug Resist.2021144441444510.2147/IDR.S32958834737584
     [Google Scholar]
  21. PapagrigorakisE. VavourakisM. VlachosC. ZachariouD GalanisA MarougklianisV Osteomyelitis caused by ralstonia mannitolilytica, a rare opportunistic pathogen.2022Available from: https://www.cureus.com/articles/90840-osteomyelitis-caused-by-ralstonia-mannitolilytica-a-rare-opportunistic-pathogen 10.7759/cureus.24151
  22. TianX. JingN. DuanW. WuX. ZhangC. WangS. YanT. Septic shock after kidney transplant: a rare bloodstream ralstonia mannitolilytica infection.Infect. Drug Resist.2022153841384510.2147/IDR.S37017035899082
     [Google Scholar]
  23. LiuJ. PetersB.M. YangL. YuH. FengD. ChenD. XuZ. Antimicrobial treatment on a catheter-related bloodstream infection (CRBSI) case due to transition of a multi-drug-resistant ralstonia mannitolilytica from commensal to pathogen during hospitalization.Antibiotics20221110137610.3390/antibiotics1110137636290034
     [Google Scholar]
  24. AldhafeeriW.F. HabalrihF. Al OmarA.H. AltamimiA.A. AlshahraniM.S. AbdullahJ. AlrabieA. ShahS. Postoperative cerebrospinal fluid infection by Ralstonia mannitolilytica : Two case reports and a literature review.Surg. Neurol. Int.20221360210.25259/SNI_952_202236761260
     [Google Scholar]
  25. KimJ. ThomasL. BhavanK. SaxenaR. Rare case of Ralstonia mannitolilytica peritonitis in an adult peritoneal dialysis patient.Clin. Nephrol. Case Stud.202311111712010.5414/CNCS11120237533547
     [Google Scholar]
  26. KanoY KikuchiK. Ralstonia mannitolilytica bacteremia stemming from frequent outpatient intravenous injections at a local clinic.Cureus20231510e4788710.7759/cureus.47887
     [Google Scholar]
  27. HaddadinY. AnnamarajuP. RegunathH. Central Line–Associated Blood Stream Infections.StatPearls.Treasure Island, FLStatPearls Publishing2023Available from: https://www.ncbi.nlm.nih.gov/books/NBK430891/
    [Google Scholar]
  28. TrautnerB.W. DarouicheR.O. Role of biofilm in catheter-associated urinary tract infection.Am. J. Infect. Control200432317718310.1016/j.ajic.2003.08.00515153930
     [Google Scholar]
  29. MeherB. Materiovigilance: An Indian perspective.Perspect. Clin. Res.20189417517810.4103/picr.PICR_26_1830319948
     [Google Scholar]
  30. KantiS.P.Y. CsókaI. Jójárt-LaczkovichO. AdalbertL. Recent advances in antimicrobial coatings and material modification strategies for preventing urinary catheter-associated complications.Biomedicines20221010258010.3390/biomedicines1010258036289841
     [Google Scholar]
  31. RamachandranK ShettyAP ShanmuganathanR Ralstonia mannitolilytica as a rare cause of spondylodiscitis following endoscopic lumbar discectomy- A report of two cases.J Clin Orthop Trauma20234210220510.1016/j.jcot.2023.102205
     [Google Scholar]
  32. ZongZ.Y. PengC.H. Ralstonia mannitolilytica and COPD: a case report.Eur. Respir. J.20113861482148310.1183/09031936.0004601122130767
     [Google Scholar]
  33. WangZ LiuH WangF A refined view of airway microbiome in chronic obstructive pulmonary disease at species and strain-levels.Front Microbiol202011175810.3389/fmicb.2020.0175832849386
     [Google Scholar]
  34. LinT.C. WuR.X. ChiuC.C. YangY.S. LeeY. LinJ.C. ChangF.Y. The clinical and microbiological characteristics of infections in burn patients from the Formosa Fun Coast Dust Explosion.J. Microbiol. Immunol. Infect.201851226727710.1016/j.jmii.2016.08.01928705768
     [Google Scholar]
  35. DaroyM.L.G. LopezJ.S. TorresB.C.L. LoyM.J. TuañoP.M.C. MatiasR.R. Identification of unknown ocular pathogens in clinically suspected eye infections using ribosomal RNA gene sequence analysis.Clin. Microbiol. Infect.201117577677910.1111/j.1469‑0691.2010.03369.x21521414
     [Google Scholar]
  36. FerroniA. Sermet-GaudelusI. AbachinE. Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center.J Clin Microbiol200240103793379710.1128/JCM.40.10.3793‑3797.2002
     [Google Scholar]
  37. SegondsC. PauteS. ChabanonG. Use of amplified ribosomal DNA restriction analysis for identification of Ralstonia and Pandoraea species: interest in determination of the respiratory bacterial flora in patients with cystic fibrosis.J. Clin. Microbiol.20034173415341810.1128/JCM.41.7.3415‑3418.200312843108
     [Google Scholar]
  38. FerroniA. Sermet-GaudelusI. AbachinE. QuesnesG. LenoirG. BercheP. GaillardJ. Caractéristiques phénotypiques et génotypiques des souches atypiques de bacilles à Gram négatif non fermentants isolées chez des patients atteints de mucoviscidose.Pathologie Biologie200351740541110.1016/S0369‑8114(03)00021‑X
     [Google Scholar]
  39. MoissenetD. BingenE. ArletG. Vu-ThienH. Mucoviscidose : identification des bacilles isolés d’infections bronchiques par séquençage du gène de l’ARN ribosomal 16S.Pathol. Biol.2005538-950050210.1016/j.patbio.2005.06.00416081224
     [Google Scholar]
  40. CostasM. HolmesB. SlossL.L. HeardS. Investigation of a pseudo-outbreak of ‘Pseudomonas thomasii’ in a special-care baby unit by numerical analysis of SDS–PAGE protein patterns.Epidemiol. Infect.1990105112713710.1017/S09502688000477252384139
     [Google Scholar]
  41. CoenyeT. SpilkerT. ReikR. VandammeP. LiPumaJ.J. Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis.J. Clin. Microbiol.20054373463346610.1128/JCM.43.7.3463‑3466.200516000479
     [Google Scholar]
  42. CoenyeT. GorisJ. SpilkerT. VandammeP. LiPumaJ.J. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov.J. Clin. Microbiol.20024062062206910.1128/JCM.40.6.2062‑2069.200212037065
     [Google Scholar]
/content/journals/cdrr/10.2174/0125899775287020240424071322
Loading
Ralstonia mannitolilytica Infections: A Systematic Review of Case Reports Unveiling Clinical Patterns and Therapeutic Insights
Current Drug Research Reviews 17, 293 (2025); https://doi.org/10.2174/0125899775287020240424071322
/content/journals/cdrr/10.2174/0125899775287020240424071322
/content/journals/cdrr/10.2174/0125899775287020240424071322
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article. Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): case report; catheter-related infections; emerging pathogens; Pseudomonas thomasii; Ralstonia mannitolilytica; systematic review

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test